Target intelligence / Profile preview

Pathogenic bacteria cell wall and membrane integrity

Molecular classification
Other (not a single protein or receptor; refers to structural and functional components of bacterial cells)
01

Overview

The pathogenic bacteria cell wall and membrane integrity refer collectively to the structural features that maintain bacterial shape and protect against environmental stresses. The main component is peptidoglycan in most bacteria—a mesh-like polymer that provides rigidity—while gram-negative species also possess an additional outer lipopolysaccharide-containing membrane. These structures are essential targets for many antibiotics because their disruption leads directly to bacterial death via osmotic lysis or loss of essential barrier functions. Drugs targeting these structures include β-lactams (penicillins), glycopeptides (vancomycin), bacitracin, polymyxins (colistin/polymyxin B/E), and lipopeptides like daptomycin. Bacteria can adapt by modifying their cell walls or switching between different forms with reduced dependence on these structures as part of resistance mechanisms.

Other names
Bacterial cell envelopeBacterial outer membraneBacterial cytoplasmic membranePeptidoglycan layer (for Gram-positive)Lipopolysaccharide layer (for Gram-negative)Cell wall biosynthesis machineryMembrane permeability barrier
02

Mechanism of action

Inhibition of peptidoglycan synthesis leading to weakened cell walls and osmotic lysis; Disruption of outer or cytoplasmic membranes causing loss of structural integrity; Insertion into membranes leading to leakage of cellular contents. Specifically: β-lactams inhibit transpeptidase enzymes involved in peptidoglycan cross-linking; Glycopeptides bind directly to peptidoglycan precursors; Bacitracin blocks lipid carrier recycling needed for peptidoglycan synthesis; Polymyxins interact with lipopolysaccharide in gram-negative bacteria’s outer membrane; Lipopeptides insert into cytoplasmic membranes of gram-positive bacteria.

03

Biological functions

Maintenance of cellular structure and shapeProtection against osmotic lysisBarrier to environmental stress and host defensesSelective permeability for nutrients and waste products
04

Disease associations

Infection
05

Safety considerations

Potential toxicity due to off-target effects on host cells at high dosesDevelopment of resistance through modification or degradation of cell wall/membrane componentsLimited spectrum activity for some agents targeting only certain bacterial types
06

Interacting drugs

β-lactams (e.g., penicillins)

4 more in the full profile.

Beyond the preview

Go deeper on Pathogenic bacteria cell wall and membrane integrity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria cell wall and membrane integrity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call